ISMAAR Symposium 2020, Saturday 22 February, Copenhagen
Page URL: https://www.bionews.org.uk/page_20043
CONTENTS Issue #680
COMMENT
Personalised medicine: a reality check
NEWS DIGEST
REVIEWS
Book Review: Reproductive Health Psychology
BioNews Appeal: Please donate HERE to keep BioNews independent and FREE to read

You are currently viewing the Alert version of the BioNews email newsletter.

Click the tab above to view the Full Text version

Welcome to BioNews by email, published by the Progress Educational Trust, providing you with news, comment and reviews on genetics, assisted conception, embryo/stem cell research and related areas. 


Visit the BioNews website at www.bionews.org.uk where you can subscribe for free to receive BioNews by email in one of three formats, and search the archive of more than 8,000 articles.

Personalised medicine: a reality check
5 November 2012 - by Professor Donna Dickenson
The soaring promises made by personalised medicine advocates are probably loftier than in any other medical or scientific realm today. Francis Collins, former co-director of the Human Genome Project, wrote: 'We are on the leading edge of a true revolution in medicine, one that promises to transform the traditional "one size fits all" approach into a much more powerful strategy'... [Read More]
Myriad Genetics holding genetic data as trade secrets
5 November 2012 - by Antony Starza-Allen
A group of academics has accused Myriad Genetics, the US biotech company that holds patents over the BRCA1 and BRCA2 genetic tests for increased risk of breast cancer, of keeping secret clinical data obtained from the tests by saying the information is commercially sensitive... [Read More]
Glasgow centre buyout births UK's largest IVF provider
5 November 2012 - by Cait McDonagh
The Academic Research Partnership (ARP) has bought a majority stake in the Glasgow Centre for Reproductive Medicine (GCRM), reportedly creating the UK's largest provider of NHS and private IVF services... [Read More]
Human genetic variation mapped from 1,000 genomes
5 November 2012 - by Dr Nicola Davis
Over 1,000 people from 14 countries have had their genomes mapped by scientists. The researchers say their study will help them examine genetic variations at the scale of national populations and further identification of the rare genetic variations related to many diseases... [Read More]
Private sperm donor ordered to pay child support
5 November 2012 - by Joseph Jebelli
A man who donated his sperm to a lesbian couple 13 years ago in a private arrangement has been ordered to pay child support. He has called on the Government to make changes in the law so that private sperm donors are treated fairly.... [Read More]
Gene mutation melanoma drug recommended for NHS use
5 November 2012 - by Maria Sheppard
A drug which prolongs life in a form of skin cancer associated with a genetic mutation has been recommended for use on the NHS... [Read More]
Gene therapy approved in Europe for first time
5 November 2012 - by Dr Lucy Spain
The European Medicines Agency (EMA) has approved Glybera, a gene therapy to treat a rare genetic condition, lipoprotein lipase deficiency (LPLD), for sale across Europe. Glybera is the first gene therapy to be approved for the Western market and offers the first therapeutic treatment for people with LPLD.... [Read More]
Stem cell procedure to treat infertility after chemo tested in primates
5 November 2012 - by Dr Greg Ball
Banked sperm-producing stem cells have been used to restore sperm production in monkeys made infertile by chemotherapy treatment... [Read More]
Book Review: Reproductive Health Psychology
5 November 2012 - by Professor Eric Blyth
This comprehensive handbook is written for psychologists and other health-care professionals and covers reproductive health across the lifespan. It will be of considerable value to both undergraduate and post-graduate students who are studying reproductive health... [Read More]

Advertising in BioNews

BioNews is read by around 18,000 people every week. Our readership is predominantly in the UK, but we have subscribers in 44 countries. That is a lot of people with an interest in assisted conception, genetics, embryo/stem cell research and related areas.

Advertisements (up to 300 words in length) start from as little as £75, making BioNews a very cost effective way to reach your target audience.

The Progress Educational Trust can personally vouch for the service, as the charity has itself successfully engaged members of staff via BioNews. Why not save money by recruiting through BioNews, and help keep BioNews FREE at the same time?

If you would like further information about advertising a job or opportunity in BioNews, please contact Sarah Norcross on +44 (0)20 7278 7870 or at snorcross@progress.org.uk

Sarah Norcross
Director, Progress Educational Trust
140 Gray's Inn Road
London, WC1X 8AX